Thursday, April 30, 2020

Covid-19 evolution: One strain overwhelms others

Analysing more than 3,600 strains of Covid-19, two Indian geneticists have found that one particular type of the virus called Type-A2a now sweeps the world replacing even the parental strain found in Wuhan.

Like all viruses, the novel coronavirus-2019 too has evolved into new types over time and during its spread to different parts of the world. Currently, there are 11 types of the virus of which type-O is the ancestral type that was originally reported from China in December 2019. One or a few mutations define the signature of each of these types.


When Nidhan Biswas and Partha Majumder, two scientists at the National Institute of Biomedical Genomics, Kalyani tracked the virus's evolution, they   found in most regions only one type (A2a) of Covid-19 has begun to overtake other types. 


The scientists collected the genome data from 55 countries up to 6, tapping a global database. Upon closer scrutiny, it showed that Type-O was carried by travelers from China to other parts of the world. Subsequently, it began to evolve inside and outside of China. 


Astonishingly, in most parts of the world, only one type (A2a) of Covid-19 proliferates overtaking others. By March-end, the A2a type  had nearly replaced all other types and became the dominant type of Covid-19 all over the world. 


A similar pattern was seen in India, which too submitted Covid-19 genetic data to the global repository accessed by the duo. Out of the 3600 samples they studied, 35 were Indians.


" The 35 viral sequences belonged to 4 types: the ancestral type -O (5), and derived types A2a (16), A3 (13) and B (1). Two types- A3 ans A2a- predominate. All persons infected with type A3 coronavirus have travel history to Iran, while most persons with type A2a have no known travel history to countries outside India. Therefore, the A2a type is also increasing in its population size within India," they said in a research paper accepted for publication in the Indian Journal of Medical Research.


The study implies that while engaging in a battle to eradicate or control Covid-19 by a vaccine or any alternative method, the overwhelming presence of Type-A2a has to be taken into account.


" We need to investigate regional differences within India in respect of viral genomic diversity and frequencies of virus types. This will inform the relationship of coronavirus type with host ethnicity, perhaps mediated through differences in frequencies of variants in genes of the immune system among ethnic groups in India", suggested the NBG scientists.



This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

Labels: , , , , , , , , , , ,

Sunday, November 06, 2016

A novel gene therapy to lower the risk of cancer!

The researchers expect that the therapy could be ready for clinical trials within five years.

 US scientists have developed a new gene therapy that can help reduce the development of cancer cells that are an infrequent but dangerous by-product of gene therapies. Gene therapy holds potential for treating genetic diseases by replacing defective genes with repaired ones. It has shown promise in clinical trials but has also been set back by difficulties in delivering genes, getting them to work for a long time and safety issues. The findings were converted into a stem cell gene therapy to target a life-threatening immune deficiency in newborns called Severe Combined Immunodeficiency (SCID-X1), also known as ‘Boy in the Bubble Syndrome’ — a genetic disorder which results in an extreme vulnerability to infectious diseases.

 Our goal is to develop a safe and effective therapy for SCID-X patients and their families,’ said Grant Trobridge, Associate Professor at Washington State University. The researchers developed a vector from a foamy retrovirus — a natural choice for gene therapy because they work by inserting their genes into a host’s genome. The team altered it to change how it interacts with a target stem cell so it would insert itself into safer parts of the genome. They found that it integrated less often near potential cancer-causing genes. Unlike other retroviruses, they don’t normally infect humans. They also are less prone to activate nearby genes, including genes that might cause cancer. The researchers expect that the therapy could be ready for clinical trials within five years. 

The developments are published in the journal of Science Reports.

this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.
https://gscrochetdesigns.blogspot.com. one can see my crochet creations

https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes

https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

Labels: , , , , , , ,